{
    "pmcid": "10294592",
    "qa_pairs": {
        "How did trimerization affect the neutralization potency of FSR16m and FSR22?": [
            "It increased their neutralization ability by more than 300-fold",
            "It decreased their neutralization ability by more than 300-fold",
            "It had no significant effect on their neutralization ability",
            "It doubled their neutralization ability"
        ],
        "What is one advantage of DARPins over traditional monoclonal antibodies in treating SARS-CoV-2?": [
            "They maintain potency against new variants due to their design strategy",
            "They are larger and more complex, allowing for better binding",
            "They require a higher dosage to achieve the same effect",
            "They are less specific, allowing for broader targeting of viral proteins"
        ],
        "What is the primary target for the DARPins FSR16m and FSR22 in neutralizing SARS-CoV-2?": [
            "The receptor-binding domain (RBD) of the spike protein",
            "The nucleocapsid protein of the virus",
            "The membrane protein of the virus",
            "The envelope protein of the virus"
        ],
        "What method was used to study the binding of FSR16m and FSR22 to the spike protein?": [
            "Cryo-electron microscopy (cryo-EM)",
            "X-ray crystallography",
            "Nuclear magnetic resonance (NMR) spectroscopy",
            "Mass spectrometry"
        ],
        "Which variants of concern were FSR16m and FSR22 able to neutralize effectively?": [
            "B.1.351 (Beta), B.1.617.2 (Delta), and BA.1.1 (Omicron)",
            "B.1.1.7 (Alpha), B.1.429 (Epsilon), and P.1 (Gamma)",
            "B.1.526 (Iota), B.1.525 (Eta), and C.37 (Lambda)",
            "B.1.621 (Mu), B.1.427 (Epsilon), and B.1.525 (Eta)"
        ]
    }
}